Drug recall · November 11, 2015
Fenoglide recall
Why: Failed Dissolution Specifications: Failed 24 month dissolution testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.
- Lots / codes
Lot # 1300939, Expiry: March 2016.
- Quantity
- 3341 Bottles
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- U.S. Nationwide
- Initiated
- September 4, 2015 · Voluntary: Firm initiated
- Classified
- November 3, 2015
- Reported
- November 11, 2015
- Ended
- March 14, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fenofibrate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.